摘要
为了解2013年中国国内药理学学科发展的特点,该文对中国学者2013年发表的国内论文进行研究,希望通过数据的解读帮助科研人员了解该领域的发展趋势。该研究在2011年12月出版《北大中文核心期刊目录(第6版)》中的药学期刊中检索2013年中国作者发表药理学文章情况,结果显示,2013年中国作者共发表药学文献5 450篇,其中药理学文献3 842篇。从发表文章的数量上看,中药和天然产物研究在我国药理学研究领域中最为集中。发文涉及的研究机构以大学为主,科研院所及临床医院较少。由此可见,2013年我国药理学学科取得了长足的发展,但仍面临严峻的挑战,学科建设依旧任重道远。
This article is to investigate the characteristics of pharmacology development in China and to help Chinese scien-tists have a good look at latest progress in this field by analysing the articles published in domestic journals in 201 3.Articles pub-lished in domestic pharmacy related journals originating from the 201 1 edition of A Guide to the Core Journals of China were re-trieved.There were 5450 articles with Chinese authors published in domestic pharmacy related journals in 201 3,including 3842 pharmacology articles.According to the number of articles,the researches mainly concentrate on traditional Chinese medicine and natural products.Universities and colleges were the main organizations in paper publishment in China.The number of ar-ticles from research institutes and hospitals was much lower. Pharmacology in China has achieved considerable progress in 201 3,but challenges still remain.More should be done in disci-pline construction.
出处
《中国药理学通报》
CAS
CSCD
北大核心
2014年第12期1629-1632,共4页
Chinese Pharmacological Bulletin
基金
中国科学技术协会学会能力提升专项-优秀科技社团奖
国家科技部“重大新药创制”科技重大专项资助项目(No2013ZX09102106)
关键词
药理学
学科发展
国内论文
研究机构分析
研究领域分析
研究现状
pharmacology
discipline development
domestic papers
research institution analysis
research area analysis
research status
